Bilaketaren emaitzak - Anastasia G Eleftheraki

  • Erakusten 1 - 8 emaitzak -- 8
Findu emaitzak
  1. 1
    Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

    Volumetric and MGMT parameters in glioblastoma patients: Survival analysis nork Georgios Iliadis, Vassiliki Kotoula, Athanasios Chatzisotiriou, Despina Televantou, Anastasia G Eleftheraki, Sofia Lambaki, Despina Misailidou, Panagiotis Selviaridis, George Fountzilas

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Identification and Validation of a Multigene Predictor of Recurrence in Primary Laryngeal Cancer

    Identification and Validation of a Multigene Predictor of Recurrence in Primary Laryngeal Cancer nork Elena Fountzilas, Vassiliki Kotoula, Nikolaos Angouridakis, Ilias Karasmanis, Ralph M. Wirtz, Anastasia G Eleftheraki, Elke Veltrup, Konstantinos Markou, Angelos Nikolaou, Dimitrios Pectasides, George Fountzilas

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

    Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomiz... nork George Fountzilas, E. Ciuleanu, Mattheos Bobos, Anna Kalogera‐Fountzila, Anastasia G Eleftheraki, Georgia Karayannopoulou, T. Zaramboukas, Angelos Nikolaou, Konstantinos Markou, Liliana Resiga, Dimitrios Dionysopoulos, E. Samantas, H. Athanassiou, D. Misailidou, Dimostenis Skarlos, Tudor‐Eliade Ciuleanu

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf

    A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf nork James D. Chalmers, Abhya Gupta, Sanjay H. Chotirmall, April W. Armstrong, Peter Eickholz, Naoki Hasegawa, Pamela J. McShane, Anne E. O’Donnell, Michal Shteinberg, Henrik Watz, Anastasia G Eleftheraki, Claudia Diefenbach, Wiebke Sauter

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study

    Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study nork James D. Chalmers, Michal Shteinberg, Marcus Mall, Anne E. O’Donnell, Henrik Watz, Abhya Gupta, E. Frahm, Anastasia G Eleftheraki, J. Rauch, Sanjay H. Chotirmall, April Armstrong, Peter Eickholz, Naoki Hasegawa, Wiebke Sauter, Pamela J. McShane

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

    Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-cont... nork Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, Ulf Müller‐Ladner, Meera Ramanujam, Bernd Rosenstock, Anastasia G Eleftheraki, Richard Vinisko, Alena Petříková, Herbert Kellner, Eva Dokoupilová, Brygida Kwiatkowska, Rieke Alten, Christian Schwabe, Patrick Baum, David Joseph, Jay S. Fine, Steven J. Padula, Jürgen Steffgen

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

    XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with coll... nork Dimitrios Pectasides, George Papaxoinis, Konstantine T. Kalogeras, Anastasia G Eleftheraki, Ioannis Xanthakis, Thomas Makatsoris, E. Samantas, Ioannis Varthalitis, Pavlos Papakostas, Nikitas Nikitas, Christos N. Papandreou, George Pentheroudakis, Eleni Timotheadou, Angelos Koutras, Joseph Sgouros, Dimitrios Bafaloukos, G. Klouvas, Theofanis Economopoulos, Konstantinos N. Syrigos, George Fountzilas

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

    HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy nork George Fountzilas, Christos Valavanis, Vassiliki Kotoula, Anastasia G Eleftheraki, Konstantine T. Kalogeras, Olympia Tzaida, Anna Batistatou, Ralf Kronenwett, Ralph M. Wirtz, Mattheos Bobos, Eleni Timotheadou, Nikolaos Soupos, George Pentheroudakis, Helen Gogas, Dimitrios Vlachodimitropoulos, Genovefa Polychronidou, Gerasimos Aravantinos, Angelos Koutras, Christos Christodoulou, Dimitrios Pectasides, P. Arapantoni

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: